Showing results (81-90 of 271) with videos related to
Sort By:
Pageof 28
Skin Therapy Letter|January 26, 2017
A Review of Brodalumab, an IL-17 Receptor Antagonist, for Moderate-to-Severe Plaque PsoriasisY Tong, A J Peranteau, Z Nawas, et al.Cancer Research|July 11, 1992
p53 mutations in basal cell carcinomasP Rady, F Scinicariello, R F Wagner, et al.Skin Therapy Letter|March 19, 2005
Valacyclovir for the management of herpes viral infectionsA Chakrabarty, N J Anderson, R Beutner, et al.Cellular Immunology|June 1, 1986
Interferon-mediated protection of B16 melanoma cells from cytotoxicity by activated macrophagesM Sarzotti, S Baron, S K Tyring, et al.European Journal of Epidemiology|September 1, 1987
Condyloma acuminatum: epidemiological, clinical and therapeutic aspectsS K Tyring, R Cauda, S Baron, et al.Archives of Dermatology|June 1, 1989
Natural killer cell activity is reduced in patients with severe forms of inherited epidermolysis bullosaS K Tyring, V Chopra, L Johnson, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2003
Risk contribution of sexual behavior and cigarette smoking to cervical neoplasiaC H Sierra-Torres, S K Tyring, W W AuBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
A guide to immunotherapy of genital warts: focus on interferon and imiquimodA J Czelusta, T Evans, I Arany, et al.Archives of Dermatological Research|August 15, 1998
Induction by interferon-gamma of its receptor varies with epithelial differentiation and cell typeI Arany, S K Tyring, H Brysk, et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 8, 1998
Synergism of dimethoxybenzosemiquinone free radicals and CD4+ T-lymphocytes to suppress Ehrlich ascites tumorC D Morgan, S S Lefkowitz, J EversePageof 28